NDC 60687-266
Raloxifene Hydrochloride 60 mg tablet
On the label: American Health Packaging. It's repackaged: American Health Packaging rebottles it from Cipla USA., Inc.'s NDC 69097-825.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| InvaGen Pharmaceuticals, Inc | Hauppauge, NY, United States | Makes it and tests it | No problems foundOct 25, 2023 · 18 inspections |
| InvaGen Pharmaceuticals, Inc | Central Islip, NY, United States | Tests it and packages it | Problems found, fixed voluntarilyJul 17, 2026 · 4 inspections |
Repackaging site
- American Health Packaging, Columbus, OH, United States · repackages it
Recalls
- Dec 4, 2019 · Class II · American Health Packaging
Failed Dissolution Specifications: Low out of specification results obtained during stability testing.
Lots: Lot #:180276A, Exp date 02/29/2020
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Raloxifene: every company that makes it
- Form
- tablet, oral
- Strength
- 60 mg
- Approval
- ANDA ANDA090842
- On the market since
- Nov 9, 2016
- Package NDCs
60687-266-1160687-266-21- Official label
- DailyMed (National Library of Medicine), updated Nov 4, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?